Platelet Rich Plasma as Monotherapy in Androgenetic Alopecia
September 2025
in “
Journal of Neonatal Surgery
”

TLDR PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.
This pilot study investigated the effects of Platelet Rich Plasma (PRP) therapy as a monotherapy for androgenetic alopecia in a hospital setting, involving subjects aged 18-40 years with specific classifications of male and female pattern baldness. Over 6 months, PRP was prepared from the patients' blood and injected monthly into the alopecic areas. Results showed a significant reduction in hair loss, with the mean hair pull test score decreasing from 5.44 to 0.38, and an increase in hair density from 96.54 to 106.92/cm². The study concluded that PRP shows promise as a treatment for androgenetic alopecia, but highlighted the need for further research with comparative groups to better understand its efficacy.